These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 26617859)
1. Tumor-stroma ratio is an independent predictor for survival in NSCLC. Zhang T; Xu J; Shen H; Dong W; Ni Y; Du J Int J Clin Exp Pathol; 2015; 8(9):11348-55. PubMed ID: 26617859 [TBL] [Abstract][Full Text] [Related]
2. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma. Wang K; Ma W; Wang J; Yu L; Zhang X; Wang Z; Tan B; Wang N; Bai B; Yang S; Liu H; Zhu S; Cheng Y J Thorac Oncol; 2012 Sep; 7(9):1457-61. PubMed ID: 22843085 [TBL] [Abstract][Full Text] [Related]
3. [Tumor-stroma ratio is an independent prognostic factor of non-small cell lung cancer]. Wang Z; Liu H; Zhao R; Zhang H; Liu C; Song Y Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):191-6. PubMed ID: 23601299 [TBL] [Abstract][Full Text] [Related]
4. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer. Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer. Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the tumor-stroma ratio in gallbladder cancer. Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165 [TBL] [Abstract][Full Text] [Related]
7. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer. Cao X; Chen YZ; Luo RZ; Zhang L; Zhang SL; Zeng J; Jiang YC; Han YJ; Wen ZS Oncotarget; 2015 May; 6(13):11704-13. PubMed ID: 25868976 [TBL] [Abstract][Full Text] [Related]
9. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected. Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis. Deng XF; Liu QX; Zhou D; Min JX; Dai JG Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247 [TBL] [Abstract][Full Text] [Related]
11. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation. Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of vascular and lymphovascular invasion in early lung cancer. Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645 [TBL] [Abstract][Full Text] [Related]
14. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection. Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495 [TBL] [Abstract][Full Text] [Related]
15. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer. Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087 [TBL] [Abstract][Full Text] [Related]
16. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer. Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115 [TBL] [Abstract][Full Text] [Related]
18. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers. Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742 [TBL] [Abstract][Full Text] [Related]
19. The tumor-stroma ratio is an independent predictor for survival in nasopharyngeal cancer. Zhang XL; Jiang C; Zhang ZX; Liu F; Zhang F; Cheng YF Oncol Res Treat; 2014; 37(9):480-4. PubMed ID: 25231688 [TBL] [Abstract][Full Text] [Related]
20. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy. Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]